20
PharmAbcine
208340.KQ·KOSDAQDaejeon KRFounded 2006100 employees
Micro CapbiotechPublicOncology
Platform: TTAC-0001 VEGF
Market Cap
$0.15B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (208340.KQ)
Loading 208340.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 208-7575 | 208-7575 | Phase 2/3 | 1 | VEGF | GISTADHD | ||
| 208-4501 | 208-4501 | Phase 2/3 | 1 | CD3 | Schizophrenia |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
PharmAbcine trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)